Clinical Trial Update: Efficacy and Safety of Lapaquistat Acetate Coadministered With Atorvastatin in Subjects With Hypercholesterolemia [Phase 2]

View source ↗

Summary

Phase 2 study assessing the efficacy and safety of lapaquistat acetate coadministered with atorvastatin in adults with hypercholesterolemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypercholesterolemia

Drugs mentioned

• Lapaquistat Acetate (lapaquistat acetate)
• atorvastatin (atorvastatin)

Snippet

Sponsor: Takeda | Conditions: Hypercholesterolemia | Phase 2 | Status: COMPLETED